Nuclear hormone and peptide hormone therapeutics for NAFLD and NASH

Nuclear hormone and peptide hormone therapeutics for NAFLD and NASH

Background: Non-alcoholic steatohepatitis (NASH) is a spectrum of histological liver pathologies ranging from hepatocyte fat accumulation, hepatocellular ballooning, lobular inflammation, and pericellular fibrosis. Based on early investigations, it was discovered that visceral fat accumulation, hepa...

Full description

Bibliographic Details
Main Authors: Brian Finan, Sebastian D. Parlee, Bin Yang
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:Molecular Metabolism
Subjects:
Nuclear hormone
Peptide hormone
NAFLD
NASH
Clinical data
Online Access:http://www.sciencedirect.com/science/article/pii/S2212877820302271

Internet

http://www.sciencedirect.com/science/article/pii/S2212877820302271

Similar Items